CWC
RVMD icon

Carolinas Wealth Consulting’s Revolution Medicines RVMD Stock Holding History

Carolinas Wealth Consulting’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,023
Closed -$29.3K – 1134
2023
Q4 		$29.3K Hold
1,023
– – 0.01% 398
2023
Q3 		$20.3K Hold
1,023
– – 0.01% 431
2023
Q2 		$27.4K Hold
1,023
– – 0.01% 428
2023
Q1 		$22.2K Hold
1,023
– – ﹤0.01% 478
2022
Q4 		$24.4K Hold
1,023
– – 0.01% 460
2022
Q3 		$20K Hold
1,023
– – 0.01% 444
2022
Q2 		$20K Hold
1,023
– – 0.01% 449
2022
Q1 		$26K Hold
1,023
– – 0.01% 437
2021
Q4 		$26K Hold
1,023
– – 0.01% 446
2021
Q3 		$28K Hold
1,023
– – 0.01% 421
2021
Q2 		$32K Buy
+1,023
New +$35.7K 0.01% 421

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Carolinas Wealth Consulting's RVMD Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Revolution Medicines (RVMD) in Q1 2024, closing a stake of 1,023 shares — an estimated $29.3K sold.

Carolinas Wealth Consulting first reported a position in RVMD in Q2 2021 and held it in 11 quarters. The position peaked at $32K in Q2 2021. 210 funds tracked by Wall St. Rank hold RVMD as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Revolution Medicines position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 1,023 Revolution Medicines shares in Q1 2024, an estimated $29.3K.
  • Carolinas Wealth Consulting first reported a position in Revolution Medicines in Q2 2021 and held it in 11 quarters.
  • Carolinas Wealth Consulting's Revolution Medicines position peaked at $32K in Q2 2021.
  • 210 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.